Creative biogene

05/28/2026

Creative Biogene provides a comprehensive miRNA luciferase reporter assay service designed to validate miRNA targets with precision and efficiency. https://integraterna.creative-biogene.com/service/mirna-luciferase-array-service.html

05/27/2026

Creative Biogene has established a comprehensive biochemical screening and analysis platform for apoptosis research. The platform enables cell-free evaluation of compound interactions with key apoptotic targets and their effects on enzyme activity, providing precise and controllable mechanistic data. https://www.creative-biogene.com/Services/Drug-Discovery-Services/Apoptosis-Biochemical-Screening-and-Profiling.html

05/22/2026

Creative Biogene provides customized fatty acid-conjugated oligonucleotide services, including C16, C18, and C22. Fatty acid conjugation enhances oligonucleotide cellular uptake efficiency and biodistribution, enabling efficient targeted delivery of siRNA and A*O in various cell types and tissues. https://integraterna.creative-biogene.com/services/fatty-acid-oligonucleotide-conjugation.html

05/20/2026

To obtain more specific biophysical and pharmacological analysis, scientists simplify ion channels by expressing them in cultured, non-neuronal cell lines. Creative Biogene has the most extensive collection of cell lines stably expressing functional ion channels, including Nav, Cav, ERG, and others. These cell lines are carefully selected for optimal performance, thus ensuring a high level of accuracy and precision in the assays.

Creative Biogene has the most extensive collection of cell lines stably expressing functional ion channels, including Nav, Cav, ERG and others.

05/15/2026

Creative Biogene has developed a Single-domain Antibody-Oligonucleotide Conjugation (sdAb-Oligo) platform designed to unlock delivery spaces that are inaccessible to conventional antibodies, Fab fragments, lipid nanoparticles, or GalNAc systems, enabling the next wave of RNA-based precision medicines. https://integraterna.creative-biogene.com/sdab-oligonucleotide-conjugation.html

05/12/2026

At Creative Biogene, our reporter genes knock-in platform combines years of expertise in genome editing and cell engineering. We offer high-efficiency integration of fluorescent proteins, luciferases, and epitope tags into safe-harbor loci such as Rosa26, AAVS1, and HPRT, or directly into target gene loci. This ensures long-term stable expression without affecting host cell proliferation, differentiation, or physiological functions.

05/08/2026

Meet Creative Biogene at ASGCT 2026 Annual Meeting

04/28/2026

Creative Biogene delivers comprehensive and customizable CAR-T and CAR-NK cell manufacturing services tailored to diverse research needs. Leveraging extensive lentiviral packaging capabilities, a robust CAR library, and scalable workflows, we provide high-yield, high-fidelity cell products optimized for functional assays, animal models, or translational pipeline validation. https://www.creative-biogene.com/Services/Stable-cell-line-generation/CAR-T/CAR-NK-Cells-Generation-Service.html

04/24/2026

Building on years of expertise in oligonucleotide chemistry, Creative Biogene offers a comprehensive suite of services for the synthesis of GalNAc-conjugated oligonucleotides. From initial design to large-scale production, our services are tailored to support the successful development of GalNAc-based oligonucleotide drugs.

IntegrateRNA offers GalNAc-siRNAs, GalNAc-A*Os, GalNAc-antagomiRs and GalNAc-conjugated nucleic acid therapeutics.

04/22/2026

Creative Biogene leverages the precision of CRISPR/Cas9 technology combined with the homologous recombination (HDR) repair pathway to offer a comprehensive Stable Gene Knock-in Cell Line Construction Service. This service enables accurate insertion ranging from single-nucleotide mutations to large therapeutic gene fragments. https://www.creative-biogene.com/services/stable-cell-line-generation/stable-knock-in-cell-line-generation.html